Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine
Clinical trial NCT02969876 · TERMINATED
Trial details
- NCT number
- NCT02969876
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-24
- Primary completion
- 2018-08-06
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.